세계 벼룩 및 진드기 구제 제품 시장은 반려동물 사육 증가, 인수공통전염병에 대한 인식 증가, 해충 제어 솔루션의 발전 등으로 인해 2025-2032년의 예측 기간 동안 연평균 7.56% 성장하여 2024년 80억 4,000만 달러에서 2032년 144억 달러로 성장할 것으로 예측됩니다. 으로 성장할 것으로 예측됩니다. 촉진요인 중 하나는 반려동물 사육 증가와 반려동물의 인간화입니다. 많은 사람들이 반려동물을 키우고 가족으로 여기게 되면서 반려동물의 건강에 대한 지출 증가에 기여하고 있습니다. 라임병, 에리키아증 등 벼룩과 진드기가 매개하는 질병에 대한 인식이 높아지면서 반려동물 보호자들이 예방 치료를 요구하게 되었고, 수의사들은 계절적 사용이 아닌 연중 예방약을 처방하게 되었습니다. 기온 상승으로 기생충의 서식지와 활동 시기가 확대되고, 반려동물이 기생충에 노출될 위험이 높아지는 기후 변화도 이 시장을 견인하고 있습니다.
제품 혁신이 시장 성장의 주요 원동력이 되고 있으며, 복용이 간편한 경구용 정제, 오래 지속되는 목걸이, 천연 대체품 등 혁신적인 제품들이 압도적인 점유율을 차지하고 있습니다. 전자상거래와 펫 케어 소매업의 성장으로 이러한 제품은 그 어느 때보다 쉽게 구할 수 있으며, 정기 구매 모델은 정기적인 사용을 장려하고 있습니다. 특히 신흥국 시장의 가처분 소득 증가는 반려동물 헬스케어에 대한 지출 증가와 반려동물 보험의 보급을 촉진하는 요인으로 작용하고 있습니다. 의사의 추천이 중요한 역할을 하고, 전문가들은 처방전 등급의 약을 추천하며, 새로운 활성 성분의 규제 승인은 소비자의 신뢰를 높이고 있습니다. 또한, 록키산 반점열 등 벼룩과 진드기가 매개하는 인수공통전염병에 대한 우려도 예방 솔루션에 대한 수요를 뒷받침하고 있습니다. 향후 AI를 활용한 해충 추적, 맞춤형 반려동물 건강관리 솔루션, 아시아태평양 및 라틴아메리카 시장 성장 등 신기술이 업계 성장을 더욱 촉진할 것으로 보입니다.
예를 들어, 2023년 8월, 베링거인겔하임 인터내셔널(Boehringer Ingelheim International GmbH)은 인도에서 넥스가드(Afoxolaner) S 및 M 시장 확대를 발표하였습니다. 이번 제품 확대는 NexGard X와 L 출시 이후 소형견(2-4kg) 및 중형견(4-10kg)을 위한 NexGard 제품군을 확대한 것입니다.
위에 언급된 회사는 시장 점유율에 따른 순위를 보유하지 않으며, 조사 작업 중 이용 가능한 정보에 따라 변경될 수 있습니다.
Global flea and tick product market is projected to witness a CAGR of 7.56% during the forecast period 2025-2032, growing from USD 8.04 billion in 2024 to USD 14.40 billion in 2032, owing to a combination of increasing pet ownership, rising awareness of zoonotic diseases, and advancements in pest control solutions. Among the drivers is increased pet ownership and humanization of pets, as more people own pets and treat them as family, contributing to increased expenditure on pet health. Increased sensitization about flea and tick-borne diseases, including Lyme disease and ehrlichiosis, has also led to pet owners demanding preventive treatment, with veterinarians prescribing year-round protection rather than seasonal use. Climate change is another driver, with warmer temperatures increasing the range and activity seasons of parasites, raising exposure risks for pets.
Product innovation has been a primary market growth driver, with innovations such as easy-to-administer oral pills, long-lasting collars, and natural alternatives commanding a dominant share. Growth of e-commerce and pet care retail has made these products more accessible than ever, while subscription models encourage regular usage. Rising disposable income, particularly in developing markets, has also supported demand, aided by rising expenditure on pet healthcare and growing acceptance of pet insurance. Doctor recommendations play an important role, with such experts recommending prescription-grade medication, while regulatory clearances of new active ingredients enhance consumer confidence. Furthermore, fears of zoonotic diseases spread by fleas and ticks, such as Rocky Mountain spotted fever, have also supported demand for preventive solutions. In the future, new technologies such as AI-based tracking of pests, customized pet healthcare solutions, and market growth in Asia-Pacific and Latin America are likely to fuel the industry's growth even further.
For instance, in August 2023, Boehringer Ingelheim International GmbH announced its expansion of NexGard (afoxolaner) S and M markets in India. The expansion comes after the launch of NexGard X and L and expands the NexGard product line for small (2-4 kg) and medium (4-10 kg) dogs.
Rising Pet Ownership and Humanization of Pets Drives the Global Flea and Tick Product Market Demand
The growing trend of pet ownership and the humanization of pets are key drivers of the demand seen in the global flea and tick product market. As more families embrace pet adoption, especially in the post-COVID-19 era, companion animals are considered part of the family, with more financial investment in their health and wellness. The change in attitude has raised awareness of the importance of pet care, especially protection from fleas and ticks, which trigger distress and disease transmission. As pets are taking a more central position in the family, owners are increasingly turning to a proactive approach in preventive care, seeking veterinarian-approved treatments for fleas and ticks. With the pet humanization trend showing no signs of slowing, the flea and tick product market is poised to see steady growth, fueled by increasing pet care spending and intense focus on the health and safety of pets.
For instance, in May 2025, FurLife Canine Essentials LLC introduced two new products, the FurLife flea and tick shampoo for dogs and cats and FurLife flea and tick spray for dogs and cats. They are natural, plant-powered alternatives that provide effective chemical-free protection against fleas, ticks and ear mites for pets at any stage of life.
Growing Awareness of Flea and Tick-Borne Diseases Expands Global Flea and Tick Product Market Size
The increasing recognition of the health implications of flea- and tick-borne diseases is driving the growth of the global flea and tick product market. Healthcare practitioners and pet guardians are becoming more conscious of diseases like lyme disease, ehrlichiosis, and anaplasmosis that can affect humans and animals. This is additional knowledge, driven by veterinary advice and public health promotion, that has led to more comprehensive year-round prevention treatments, rather than seasonal application. The zoonotic potential of these parasites has generated increased demand, with consumers wanting to protect their pets and families from infection. Pharmaceutical development, in the form of advanced oral preventatives and long-acting topical treatments, is becoming more popular as pet owners increasingly prioritize efficacy and convenience. Education campaigns from market participants and animal welfare groups continue to highlight the need for ongoing parasite control and thus drive market expansion. As recognition of vector-borne diseases gathers momentum and preventive medicine becomes the norm, the flea and tick product market are set to grow faster, with manufacturers developing increasingly advanced solutions to meet changing consumer needs.
For instance, in July 2025, MSD Animal Health announced the United States FDA approval of Bravecto Quantum (fluralaner for extended-release injectable suspension) for dogs. This innovative injectable provides 12-month protection against most tick species and fleas (representing a significant step forward in convenience for pet owners.
Dog Segment Dominates the Global Flea and Tick Product Market
Global flea and tick product market is dominated largely by the dog segment, and it commands the largest share owing to several vital factors. One of the favorite companion animals in the world, dogs are more vulnerable to flea and tick infestations than other companion animals owing to their outdoor lifestyle and their closer exposure to environments where such parasites are most likely to flourish. The increased exposure has witnessed a high demand for prevention and treatment products specifically designed for the canines. Companies concentrate on products specifically designed for dogs, with a broad range of choices made available, such as spot-on products, oral chewable, medicated collars, and shampoos. The segment captures high compliance rates among pet owners, supported by veterinarian advice that promotes year-round parasite prevention. The pet humanization trend has also supported higher expenditure on the health of dogs, further driving market growth. With ongoing innovations in canine flea and tick control and rising dog ownership throughout the world, the segment is predicted to continue dominating, solidifying its position as the growth driver in the flea and tick product market.
For instance, in April 2025, MSD Animal Health (UK subsidiary) received marketing authorization from the Veterinary Medicines Directorate (VMD) for Bravecto TriUNO. This new monthly chewable formulation for dogs' targets both internal and external parasites, offering comprehensive protection in one convenient dose.
North America Region Leads the Global Flea and Tick Product Market
The North American market is recognized as the top leader in the global flea and tick product market with the largest market share. This leadership is a result of several key factors that together facilitate enormous market growth. The region initially has extremely high rates of pet ownership, particularly in the United States, where over half of household's own pets. This condition provides a significant customer base for flea and tick preventatives. Further, the highly advanced pet humanization culture in North America also drives demand further as pet owners increasingly seek high-end healthcare products for their pet animals. The market is also aided by advanced veterinary infrastructure as well as a shared awareness of zoonotic diseases that parasites can transfer. Routine trips to the veterinarian and preventive healthcare have become standard practice, with veterinarians actively recommending year-round flea and tick protection. Further, North America is an innovation center for products controlling fleas and ticks, with several leading industry players based there. As pet healthcare expenditure continues to increase and product development progresses, North America is well positioned to continue its leading role in the global flea and tick product market in the near term.
For instance, in May 2025, Central Garden & Pet Company launched ADAMS Botanicals Flea & Tick Pet & Home Spray. This new EPA-approved, plant-based spray for dogs, cats, pet bedding, and home surfaces marks the brand's 50th anniversary.
Impact of the U.S. Tariff on Global Flea and Tick Product Market
The imposition of U.S. tariffs on imported goods, including pet care products, has created significant ripple effects across the global flea and tick product market. As the largest consumer of these products, U.S. trade policies directly influence pricing, supply chains, and competitive dynamics worldwide.
Tariffs on raw materials (e.g., active pharmaceutical ingredients from China and India) and finished goods have raised manufacturing costs.
Companies may pass these costs to consumers, leading to higher retail prices for flea and tick treatments, particularly for budget-conscious pet owners.
Manufacturers reliant on imported ingredients face delays and increased logistical expenses.
Key Players Landscape and Outlook
The global flea and tick product market is characterized by intense competition among leading pharmaceutical companies, insurgent innovators, and private-label companies, each pursuing different strategies to capture market share. Industry leaders dominate with their market-leading brands, supported by high research and development spending and extensive veterinary networks. Brands continue to reassert themselves in the market with innovation in oral preventatives and strategic forays in emerging markets. In the near term, the market is likely to witness seismic change through the expected expirations of patents on market-leading brands, which is expected to precipitate the launch of generics and increase price competition. The trend towards combination products with multi-parasite protection is gaining traction, driven by consumer convenience preference and the manufacturers' desire to achieve higher profit margins. As the market continues to evolve, the dynamic between incumbent players and agile disruptors will shape the competitive landscape of the future, with innovation and strategic agility emerging as key determinants in this rapidly evolving landscape.
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.